Tafamidis

Tafamidis, sold under the brand names Vyndaqel and Vyndamax, is a medication used to delay disease progression in adults with certain forms of transthyretin amyloidosis (ATTR). It can be used to treat both hereditary forms (hATTR), familial amyloid cardiomyopathy (FAC) and familial amyloid polyneuropathy (FAP), as well as wild-type transthyretin amyloidosis. It works by stabilizing the protein transthyretin. In people with ATTR, transthyretin falls apart and forms clumps (amyloids) that harm tissues including nerves and the heart.


Tafamidis, sold under the brand names Vyndaqel and Vyndamax, is a medication used to delay disease progression in adults with certain forms of transthyretin amyloidosis (ATTR). It can be used to treat both hereditary forms (hATTR), familial amyloid cardiomyopathy (FAC) and familial amyloid polyneuropathy (FAP), as well as wild-type transthyretin amyloidosis. It works by stabilizing the protein transthyretin. In people with ATTR, transthyretin falls apart and forms clumps (amyloids) that harm tissues including nerves and the heart.
Read article on Wikipedia